15.全身性エリテマトーデスの臓器病変と治療
Saved in:
Published in | 日本内科学会雑誌 Vol. 108; no. 9; pp. 1962 - 1967 |
---|---|
Main Author | |
Format | Journal Article |
Language | Japanese |
Published |
一般社団法人 日本内科学会
10.09.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-5384 1883-2083 |
DOI | 10.2169/naika.108.1962 |
Cover
Author | 藤井, 隆夫 |
---|---|
Author_xml | – sequence: 1 fullname: 藤井, 隆夫 organization: 和歌山県立医科大学附属病院リウマチ・膠原病科 |
BookMark | eNo9kDtLw1AcxS9SwVi7-i0S7yP3eu8iaPEFBRedwz_JjSbWKkkXN5vQVhcXB-niJBgUHNzUfptLH5tfwVrF5ZzhHA78zjKqtM5bGqFVgh1KhFprQXwKDsHSIUrQBWQRKZlNsWQVZGFMic2ZdJdQLctiH7tMcEmYa6ENwr-Gt6NuOf14GV89mbw0xbMpeqZ4MMW1KYam6Jv83XRep_270aCc3HdHjzemU47fPieDfAUtRtDMdO3Pq-hoZ_uwvmc3Dnb365sNOyFcujb1FRbgch1in3PMQgqaBlpL4CFlCqL10Gc60kJxDiAliEBJItWsIBiBiFXR1u9ukrXhWHsXaXwG6aUHaTsOmtqb43szfE_N9eeE_zA4gdRLgH0DjoVsnw |
ContentType | Journal Article |
Copyright | 2019 一般社団法人 日本内科学会 |
Copyright_xml | – notice: 2019 一般社団法人 日本内科学会 |
DOI | 10.2169/naika.108.1962 |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1883-2083 |
EndPage | 1967 |
ExternalDocumentID | article_naika_108_9_108_1962_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DIK F5P JSF OK1 RJT |
ID | FETCH-LOGICAL-j1584-2b906a45ed0b5503d2ae2cee8a5d239af7db3efe6955aa88a6c98189e8a631af3 |
ISSN | 0021-5384 |
IngestDate | Wed Sep 03 06:30:13 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 9 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j1584-2b906a45ed0b5503d2ae2cee8a5d239af7db3efe6955aa88a6c98189e8a631af3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/naika/108/9/108_1962/_article/-char/ja |
PageCount | 6 |
ParticipantIDs | jstage_primary_article_naika_108_9_108_1962_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 2019/09/10 |
PublicationDateYYYYMMDD | 2019-09-10 |
PublicationDate_xml | – month: 09 year: 2019 text: 2019/09/10 day: 10 |
PublicationDecade | 2010 |
PublicationTitle | 日本内科学会雑誌 |
PublicationTitleAlternate | 日内会誌 |
PublicationYear | 2019 |
Publisher | 一般社団法人 日本内科学会 |
Publisher_xml | – name: 一般社団法人 日本内科学会 |
References | 12) van Vollenhoven RF, et al: Remission in SLE: closing in on the target. Ann Rheum Dis 74: 2103-2106, 2015. 8) Stohl W, et al: B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48: 3475-3486, 2003. 9) Jacob CO, et al: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 177: 2671-2680, 2006. 2) Tedeschi SK, et al: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 634-640, 2019. 10) Zhang F, et al: A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 77: 355-363, 2018. 5) Jorge A, et al: Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14: 693-703, 2018. 3) Fanouriakis A, et al: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78: 736-745, 2019. doi: 10.1136/annrheumdis-2019-215089. 4) Yokogawa N, et al: Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 69: 791-799, 2017. 6) Appel GB, et al: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20: 1103-1112, 2009. 7) Dooley MA, et al: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365: 1886-1895, 2011. 1) 東條 毅: 抗核抗体の歴史. 日内会誌 91: 2560-2566, 2002. 11) van Vollenhoven RF, et al: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73: 958-967, 2014. |
References_xml | – reference: 1) 東條 毅: 抗核抗体の歴史. 日内会誌 91: 2560-2566, 2002. – reference: 2) Tedeschi SK, et al: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 634-640, 2019. – reference: 4) Yokogawa N, et al: Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: a multicenter, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 69: 791-799, 2017. – reference: 8) Stohl W, et al: B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48: 3475-3486, 2003. – reference: 9) Jacob CO, et al: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 177: 2671-2680, 2006. – reference: 10) Zhang F, et al: A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis 77: 355-363, 2018. – reference: 11) van Vollenhoven RF, et al: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73: 958-967, 2014. – reference: 3) Fanouriakis A, et al: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78: 736-745, 2019. doi: 10.1136/annrheumdis-2019-215089. – reference: 5) Jorge A, et al: Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol 14: 693-703, 2018. – reference: 7) Dooley MA, et al: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365: 1886-1895, 2011. – reference: 12) van Vollenhoven RF, et al: Remission in SLE: closing in on the target. Ann Rheum Dis 74: 2103-2106, 2015. – reference: 6) Appel GB, et al: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20: 1103-1112, 2009. |
SSID | ssib043658134 ssj0066765 ssib002821954 ssib005879745 ssib007485360 ssib058493862 ssib000940260 ssib002484664 |
Score | 2.1889427 |
SourceID | jstage |
SourceType | Publisher |
StartPage | 1962 |
SubjectTerms | ヒドロキシクロロキン ベリムマブ ミコフェノール酸モフェチル 全身性エリテマトーデス 目標達成に向けた治療 |
Title | 15.全身性エリテマトーデスの臓器病変と治療 |
URI | https://www.jstage.jst.go.jp/article/naika/108/9/108_1962/_article/-char/ja |
Volume | 108 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 日本内科学会雑誌, 2019/09/10, Vol.108(9), pp.1962-1967 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9VAcKkVxIv4id_04J4ktZvNJrsIwuaZUpQKQgsFD2Hz8Q7v8BR5vXiyL9TqxYsH6cWT4EPBgze1_ya8tjf_gjOb5L086MHWS9jMzs7O7Gwys8nsLCF3cjC6WSq6jhRd3_EEkw7YHeO4Js8k_tYxXdycvPrEX1n3Hm2IjblTz1pRS5uDZDF9deS-kpNoFWCgV9wlewzNTogCAMqgX7iChuH6TzpmgkbLNOxQGdFIUCmoljSSNNRUhzTyMYxBBzTiVLq2Cgqcal0XpF8XVNRAGhygWUOa5qGyBUZ1hF0AXHHsVClLGW4DZAAgGtzTCbJENkJoHlocRatDgBp_GGuhoRa20KG6YwXxLakAmVfM0nxINXDrIWMK-FdUhbZKojhy8qkXAUjPs7iaKoFzyOJrK69lT4ftjx3MRnPVYa84PW1biYOHgkrLlKUZ2mGGnjW3YnGkX3UU6rsnk6VtNlzmgGWovnzklaWQksNkrE7hmZiSJdl6ZlTLMMCLzm05GXAbHGXAXOZj_tc-bh_D8M_FabuZpOD1lIstIiZ5jZW9InrcVOK-vbgHi4fTbhDYGIbHT1u-t_Iwn1zLV5MzRw3AWpy1cwUKGaj20QiBB57etL3HwZdl01yD4NgqLv1JLjeMpa6OE6nHssqgigLfmxUXfMEerIyaqErr6K2dJ-fqFdqCrsS7QOZ65iI5s1rHoFwiD5j4s_d-vD06_PVt__WXcjgqi69l8aYsPpXF27LYK4udcviz3Pp-uPNhvDs6-Lg9_vyu3Brt__h9sDu8TNaXo7XOilOfQuL0GAjhuIla8o0n8mwpgeU8z-A15oJrKY3IXA7vsiBLeN7NfSWEMVIaP1XgBStA8DkzXX6FzPef9_OrZMFwnrIs9YRwE3DcE2NYnhoYZRgFTwX8GrlfSR6_qFLNxMfR8_X_an2DnJ0-cDfJ_ODlZn4L_O1BctvOm78b1akE |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=15%EF%BC%8E%E5%85%A8%E8%BA%AB%E6%80%A7%E3%82%A8%E3%83%AA%E3%83%86%E3%83%9E%E3%83%88%E3%83%BC%E3%83%87%E3%82%B9%E3%81%AE%E8%87%93%E5%99%A8%E7%97%85%E5%A4%89%E3%81%A8%E6%B2%BB%E7%99%82&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E8%97%A4%E4%BA%95%2C+%E9%9A%86%E5%A4%AB&rft.date=2019-09-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=108&rft.issue=9&rft.spage=1962&rft.epage=1967&rft_id=info:doi/10.2169%2Fnaika.108.1962&rft.externalDocID=article_naika_108_9_108_1962_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon |